Systemic Treatment of Psoriasis with JAK Inhibitors: A Review

Psoriasis is a prevalent chronic inflammatory disease. The inflammatory response is driven by T cells and mediated by multiple cytokines such as tumor necrosis factor and the interleukins IL-17 and IL-23. Moderate-to-severe psoriasis is treated systemically, using either biologics or conventional tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kvist-Hansen, Amanda, Hansen, Peter Riis, Skov, Lone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994544/
https://www.ncbi.nlm.nih.gov/pubmed/31893355
http://dx.doi.org/10.1007/s13555-019-00347-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994544/
https://www.ncbi.nlm.nih.gov/pubmed/31893355
http://dx.doi.org/10.1007/s13555-019-00347-w

Ejemplares similares